Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761&reg;. Findings from a randomized controlled trial

Código QR

Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761&reg;. Findings from a randomized controlled trial

Natalia Bachinskaya1, Robert Hoerr2, Ralf Ihl3For the GOTADAY Study Group1Institute of Gerontology, Academy of Medical Sciences, Kiev, Ukraine; 2Clinical Research Department, Dr Willmar Schwabe Pharmaceuticals, Karlsruhe, Germany; 3Geriatric Psychiatry Center, Maria-Hilf Hospital Krefeld, Krefeld, G...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bachinskaya N, Hoerr R, Ihl R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/979b211003404fccb50cb1f39e4bd5dd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ginkgo biloba extract EGb 761® alleviates neurosensory symptoms in patients with dementia: a meta-analysis of treatment effects on tinnitus and dizziness in randomized, placebo-controlled trials
por: Spiegel R, et al.
Publicado: (2018)

Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials
por: Gauthier S, et al.
Publicado: (2014)

Ginkgo biloba extract in the treatment of tinnitus: a systematic review
por: von Boetticher A
Publicado: (2011)

Ginkgo biloba Effects on Mice Fetal Liver
por: Zehra,Uruj, et al.
Publicado: (2010)

Efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating post-stroke depression
por: Liang ZH, et al.
Publicado: (2019)

Balance Training With Vibrotactile Neurofeedback and Ginkgo Biloba Extract in Age-Related Vertigo
por: Lars Decker, et al.
Publicado: (2021)

Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
por: Mar J, et al.
Publicado: (2019)

β-Ginkgotides: Hyperdisulfide-constrained peptides from Ginkgo biloba
por: Ka H. Wong, et al.
Publicado: (2017)

Ginkgo biloba: a natural reducing agent for the synthesis of cytocompatible graphene
por: Gurunathan S, et al.
Publicado: (2014)

The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease
por: Anna Nowak, et al.
Publicado: (2021)

Neuropsychiatric symptoms and celiac disease
por: Urban-Kowalczyk M, et al.
Publicado: (2014)

Niche specificity and functional diversity of the bacterial communities associated with Ginkgo biloba and Panax quinquefolius
por: Hanan R. Shehata, et al.
Publicado: (2021)

Expression analyses in Ginkgo biloba provide new insights into the evolution and development of the seed
por: Cecilia Zumajo-Cardona, et al.
Publicado: (2021)

Development of a novel niosomal system for oral delivery of Ginkgo biloba extract
por: Jin Y, et al.
Publicado: (2013)

Ginkgo biloba Extract Reduces Hippocampus Inflammatory Responses, Improves Cardiac Functions And Depressive Behaviors In A Heart Failure Mouse Model
por: Zhang L, et al.
Publicado: (2019)

Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure.
por: Virginie Rhein, et al.
Publicado: (2010)

Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial
por: Demarin V, et al.
Publicado: (2017)

Ginkgo biloba extract and its diterpene ginkgolide constituents ameliorate the metabolic disturbances caused by recombinant tissue plasminogen activator in rat prefrontal cortex
por: Chen Z, et al.
Publicado: (2018)

Neuropsychiatric symptoms in untreated Parkinson’s disease
por: Szatmari S, et al.
Publicado: (2017)

Impact of Ginkgo biloba extract and magnetized water on the survival rate and functional capabilities of pancreatic β-cells in type 2 diabetic rat model
por: Saleh A, et al.
Publicado: (2019)

Acta Nº761
por: Banco Central de Chile
Publicado: (2019)

Contemplating stem cell therapy for epilepsy-induced neuropsychiatric symptoms
por: Rao G, et al.
Publicado: (2017)

Pilot study to examine the effects of indoor daylight exposure on depression and other neuropsychiatric symptoms in people living with dementia in long-term care communities
por: Konis K, et al.
Publicado: (2018)

Molecular cloning and characterization of three genes encoding dihydroflavonol-4-reductase from Ginkgo biloba in anthocyanin biosynthetic pathway.
por: Cheng Hua, et al.
Publicado: (2013)

Interaction of caregiver-expressed emotions and neuropsychiatric symptoms in persons with dementia: a longitudinal cohort study
por: Kay Deckers, et al.
Publicado: (2021)

Neuropsychiatric Inventory data in a Belgian sample of elderly persons with and without dementia
por: Squelard GP, et al.
Publicado: (2012)

Genome-wide characterization of bZIP gene family identifies potential members involved in flavonoids biosynthesis in Ginkgo biloba L.
por: Huan Han, et al.
Publicado: (2021)

Management of the behavioral and psychological symptoms of dementia
por: Elizabeth C Hersch, et al.
Publicado: (2008)

The merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disorders
por: Lai CKY
Publicado: (2014)

Neuropsychiatric Symptoms Exacerbate the Cognitive Impairments in Patients With Late-Life Depression
por: Min Zhang, et al.
Publicado: (2021)

Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice
por: Li L, et al.
Publicado: (2021)

A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD
por: A. Castrioto, et al.
Publicado: (2020)

Diagnostic and treatment challenges in traumatic brain injury patients with severe neuropsychiatric symptoms: insights into psychiatric practice
por: Lauterbach MD, et al.
Publicado: (2015)

Author Correction: Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
por: Sergi Valero, et al.
Publicado: (2021)

Symptom dimensions of anxiety in Parkinson’s disease: Replication study in a neuropsychiatric patient population
por: Sonja Rutten, et al.
Publicado: (2021)

Magnetothermal nanoparticle technology alleviates parkinsonian symptoms in mice
por: Sarah Hescham
Publicado: (2021)

Neuropsychiatric Disease and Treatment
Publicado: (2009)

Depressive symptoms in caregivers of patients with dementia: demographic variables and burden
por: De Fazio P, et al.
Publicado: (2015)

Behavior and neuropsychiatric manifestations in Angelman syndrome
por: Karine Pelc, et al.
Publicado: (2008)

Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review
por: Masopust J, et al.
Publicado: (2018)